# First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect

> **NCT03627494** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 66 (actual)

## Conditions studied

- Muscular Dystrophies

## Interventions

- **DRUG:** GSK3439171A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03627494
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2019-08-26
- **Final completion:** 2019-08-26
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03627494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03627494, "First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03627494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*